Your browser doesn't support javascript.
loading
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).
Lebwohl, Mark; Kircik, Leon; Lacour, Jean-Philippe; Liljedahl, Monika; Lynde, Charles; Mørch, Marie Holst; Papp, Kim A; Perrot, Jean-Luc; Gold, Linda Stein; Takhar, Amrit; Thaçi, Diamant; Warren, Richard B; Wollenberg, Andreas.
Afiliação
  • Lebwohl M; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: lebwohl@aol.com.
  • Kircik L; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Lacour JP; Department of Dermatology, University Hospital of Nice, Nice, France.
  • Liljedahl M; LEO Pharma Ballerup, Ballerup, Denmark.
  • Lynde C; Lynde Dermatology, Probity Medical Research, Markham, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Mørch MH; LEO Pharma Ballerup, Ballerup, Denmark.
  • Papp KA; K. Papp Clinical Research, Waterloo, Ontario, Canada.
  • Perrot JL; Department of Dermatology, University Hospital of St-Etienne, St-Etienne, France.
  • Gold LS; Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
  • Takhar A; Wansford and Kings Cliffe Practice, Wansford, Cambridgeshire, United Kingdom.
  • Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
  • Warren RB; Dermatology Centre, Salford Royal National Health Service Foundation Trust, Manchester National Institute for Health Research Biomedical Research Centre, University of Manchester, Manchester, United Kingdom.
  • Wollenberg A; Department of Dermatology and Allergology, Ludwig Maximilian University Munich, Munich, Germany.
J Am Acad Dermatol ; 84(5): 1269-1277, 2021 May.
Article em En | MEDLINE | ID: mdl-32950546

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Calcitriol / Betametasona / Fármacos Dermatológicos / Prevenção Secundária Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Calcitriol / Betametasona / Fármacos Dermatológicos / Prevenção Secundária Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article